Stable consolidated revenues, costs and losses for Hybrigenics
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus...
Hikma Pharma Q1 revenue rises
Hikma Pharmaceuticals, a manufacturer of a range of both branded and non-branded generic and inlicensed...
Furiex Pharmaceuticals Enters into Loan Agreement for up to $15 Million Furiex Pharmaceuticals Inc.
Furiex Pharmaceuticals, Inc. announced it has entered into a loan agreement with MidCap Financial and...
China Shenghuo Q2 sales climb 58%
China Shenghuo, engaged in the research, development, manufacture and marketing of Sanchi-based medicinal and pharmaceutical,...
Vivus reports Qnexa phase 3 study results
Vivus, a developer of therapies to address obesity, sleep apnea, diabetes and male sexual health,...
Novartis delivers strong financial results and four major approvals
Novartis' net sales rose 27% (+19% cc) to USD 14.9 billion. Currency benefited sales by...
Echo Therapeutics Announces First Quarter 2011 Financial Results
Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive,...
ELC Group announces doubled revenues
ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation announced today a total revenue increase of...
GlaxoSmithKline Pharmaceuticals Net Sales up 11.4%
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the first quarter ended 31st March...
GlaxoSmithKline Pharmaceuticals profit grows by 16%
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the first quarter ended 31st March...
